Humanized anti-tumor necrosis factor alpha receptor 2 (anti-TNFR2) antibodies and methods of use thereof to elicit an immune response against a tumor
US10988543B2 · kind B2 · utility
4Cited by
22References
17Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 10, 2016 |
| Grant date | Apr 27, 2021 |
| Priority date | — |
| Expiry date | Nov 10, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The composition of anti-TNFR2 antibodies are provided, as well as methods of their preparation and use. This includes methods for treating disorders associated with TNF and/or TNFR2, such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.